2022-07-01 | Sale | Trevi Therapeutics, Inc. TRVI | 63,569 0.0983% | $3.11 | $197,827 | -19.52% | ||
2022-06-29 | Sale | Trevi Therapeutics, Inc. TRVI | 46,128 0.0866% | $2.74 | $126,303 | -4.08% | ||
2022-05-31 | Sale | Cushman & Wakefield plc CWK | 2.92M 1.2749% | $18.39 | $53.7M | -32.83% | ||
2022-05-02 | Sale | Trevi Therapeutics, Inc. TRVI | 600 0.0011% | $2.70 | $1,620 | -9.16% | ||
2022-04-28 | Sale | Trevi Therapeutics, Inc. TRVI | 16,163 0.0269% | $2.75 | $44,385 | -17.69% | ||
2008-07-17 | Sale | The Goldman Sachs Group, Inc. GS | President and Co-COO | 12,448 0.0029% | $180.00 | $2.24M | -35.12% | |
2008-07-16 | Sale | The Goldman Sachs Group, Inc. GS | President and Co-COO | 17,149 0.004% | $171.84 | $2.95M | -31.98% | |
2008-03-24 | Sale | The Goldman Sachs Group, Inc. GS | President and Co-COO | 10,000 0.0024% | $183.00 | $1.83M | -25.37% | |
2008-03-20 | Sale | The Goldman Sachs Group, Inc. GS | President and Co-COO | 10,000 0.0022% | $172.14 | $1.72M | -25.26% | |
2008-03-19 | Sale | The Goldman Sachs Group, Inc. GS | President and Co-COO | 20,000 0.0049% | $173.68 | $3.47M | -18.61% | |
2008-01-25 | Sale | The Goldman Sachs Group, Inc. GS | President and Co-COO | 30,000 0.0073% | $200.49 | $6.01M | -13.58% | |
2007-01-16 | Sale | The Goldman Sachs Group, Inc. GS | President and Co-COO | 20,000 0.0045% | $213.51 | $4.27M | +0.54% | |
2007-01-09 | Sale | The Goldman Sachs Group, Inc. GS | President and Co-COO | 15,000 0.0034% | $203.10 | $3.05M | +5.26% |